glp 1 covered by blue cross BCBSM pulling back on GLP-1 coverage Major insurance changes are coming

Description

Reduces appetite aids weight loss Common Drugs (Examples) Exenatide Liraglutide Dulaglutide Semaglutide Lixisenatide Clinical Uses Type 2 Diabetes Mellitus (as monotherapy or combination) Obesity / weight management (especially semaglutide, liraglutide) Cardiovascular benefit: reduces major adverse CV events in T2DM with CVD Administration Subcutaneous injection (daily or weekly depending on formulation) Oral semaglutide available for some patients Adverse Effects Gastrointestinal: nausea, vomiting, diarrhea Risk of pancreatitis (rare but serious) Mild hypoglycemia if combined with sulfonylureas or insulin Injection site reactions Contraindications / Precautions Personal/family history of medullary thyroid carcinoma History of multiple endocrine neoplasia syndrome type 2 (MEN2) Severe gastrointestinal disease (gastroparesis) GLP-1 agonists = incretin mimetics

FDA thresholds, insurance cutoffs, qualifying conditions, and more.

Ageing and fertility are intertwined

Learn how Mounjaro injection works through GIP and GLP-1 hormones to support appetite control, fullness, blood sugar regulation, and weight management in Malaysia.

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.